Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70b4adcb246898471965051b9ea8b3b1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-81 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-74 |
filingDate |
2007-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac7af0674e79a453b2c7e1959e0050b2 |
publicationDate |
2011-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-PI0711119-A2 |
titleOfInvention |
microbial administration of obesity-associated intestinal peptides |
abstract |
MICROBIAN ADMINISTRATION OF INTESTINAL OBESITY ASSOCIATED PEPTIDES. The present invention relates to the microbial administration of obesity-associated peptides. More specifically the invention relates to the use of genetically modified yeast and / or lactic acid bacteria for the administration of neuropeptides and / or peptide hormones that act to stimulate or inhibit food intake and / or energy homeostasis. |
priorityDate |
2006-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |